Skip to main content
Chemomab Therapeutics Ltd. logo

Chemomab Therapeutics Ltd. — Investor Relations & Filings

Ticker · CMMB ISIN · US16385C1045 US Manufacturing
Open in API
Filings indexed 332 across all filing types
Latest filing 2020-11-16 Interim / Quarterly Rep…
Country US United States of America
Listing US CMMB

About Chemomab Therapeutics Ltd.

https://www.chemomab.com/

Chemomab Therapeutics Ltd. is a clinical-stage biotechnology company developing therapeutics for fibro-inflammatory diseases with high unmet medical needs. The company's scientific platform is based on the discovery of the soluble protein CCL24's central role in driving the cycle of fibrosis and inflammation. Its lead product candidate, nebokitug (CM-101), is a first-in-class monoclonal antibody designed to neutralize CCL24, thereby interfering with the primary pathways that promote these conditions. Nebokitug has demonstrated disease-modifying potential in multiple clinical trials and has received Orphan Drug and Fast Track designations from the U.S. FDA for the treatment of primary sclerosing cholangitis (PSC). Following positive Phase 2 results, the company is preparing for a potential Phase 3 trial for nebokitug in PSC.

Recent filings

Filing Released Lang Actions
FORM 10-Q
Interim / Quarterly Report Q3 2020
2020-11-16 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated October 20, 2020, reporting the appointment of a new CEO and CFO, and changes to the Audit Committee membership. The content focuses on management changes and committee reconstitution, with no financial statements or earnings data. The document is a current report on significant corporate events, specifically changes in senior management and board committees. This matches the description of Board/Management Information (MANG). The document length is 7549 characters, sufficient to contain detailed information about management changes. Therefore, the appropriate classification is MANG with high confidence.
2020-10-20 English
FORM 10-Q
Interim / Quarterly Report Q2 2020
2020-08-14 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated July 15, 2020, reporting the departure of a director from the company's Board of Directors. The key section is Item 5.02, which specifically addresses the departure and resignation of a board member. There is no financial data or report attached, nor is this an announcement of a financial report. The content clearly relates to changes in the company's board of directors. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under the category 'Board/Management Information' with code MANG. The document length is 3397 characters, which is relatively short but contains substantive information about management changes, not just a report publication announcement or regulatory filing. Therefore, the correct classification is MANG with high confidence.
2020-07-15 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes the departure of the CEO and CFO consulting changes, as well as strategic updates about financing and cost-saving measures. These topics fall under management changes and significant corporate events. The document is not a full annual or quarterly report, nor is it an earnings release or proxy statement. It is specifically reporting changes in senior management and other corporate developments. Therefore, the most appropriate classification is 'Board/Management Information' (MANG). The document length and detail support this classification with high confidence.
2020-07-09 English
SC 13D/A
Major Shareholding Notification
2020-05-22 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.